Afuco™ Anti-Human AOC3 ADCC Recombinant Antibody (BTT-1023), ADCC Enhanced (CAT#: AFC-043CL)

Anti-AOC3 ADCC Enhanced Antibody (BTT-1023) is an ADCC enhanced antibody produced by our Afuco™ platform. BTT1023 is a fully human monoclonal antibody targeting VAP-1 (vascular adhesion protein-1). VAP-1 is a completely new therapeutic target. The safety and efficacy of BTT1023 has earlier been investigated in small clinical trials in rheumatoid arthritis and psoriasis patients. In March 2015, BTT1023 transitioned into Phase 2 development in fibrotic conditions and received Orphan Drug Designation in the EU for the treatment of primary sclerosing cholangitis.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Primary Sclerosing Cholangitis; Psoriasis; Rheumatoid Arthritis

Product Property

  • Purity
  • >97%, by SDS-PAGE under reducing conditions
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Target

  • Alternative Names
  • AOC3; amine oxidase, copper containing 3; HPAO; SSAO; VAP1; VAP-1; membrane primary amine oxidase; copper amine oxidase; placenta copper monamine oxidase; semicarbazide-sensitive amine oxidase; amine oxidase, copper containing 3 (vascular adhesion protein 1)

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "AOC3"

Chimeric Antibody

CAT Product Name Application Type
TAB-261 Anti-Human AOC3 Recombinant Antibody (Vapaliximab) WB, FC, IP, ELISA, Neut, FuncS, IF IgG2

Mouse Antibody

CAT Product Name Application Type
TAB-137 Anti-Human AOC3 Recombinant Antibody (Vepalimomab) Neut, ELISA, IF, IP, FuncS, FC, ICC IgM

Human Antibody

CAT Product Name Application Type
TAB-045CL Human Anti-AOC3 Recombinant Antibody (TAB-045CL) ELISA Human IgG
TAB-455CQ Anti-Human AOC3 Recombinant Antibody (Timolumab) ELISA, IHC, FC, IP, IF, FuncS IgG4, κ

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-0189 Hi-Affi™ Rabbit Anti-AOC3 Recombinant Antibody (clone DS189AB) IP, IHC-P, WB Rabbit IgG

Neuroscience Antibody

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-261 Afuco™ Anti-AOC3 ADCC Recombinant Antibody (Vapaliximab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS ADCC enhanced antibody
AFC-TAB-455CQ Afuco™ Anti-AOC3 ADCC Recombinant Antibody (Timolumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody
AFC-TAB-137 Afuco™ Anti-AOC3 ADCC Recombinant Antibody (Vepalimomab), ADCC Enhanced Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-043CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare